Science Explorer Back to mapMap
Discussion
Researcher · Agios Pharmaceuticals (United States) · United States

Shengfang Jin

Shengfang Jin publishes mostly in Molecular Biology, Cancer Research and Oncology, on topics such as Cancer, Hypoxia, and Metabolism, Glioma Diagnosis and Treatment and Amino Acid Enzymes and Metabolism.

OpenAlex
World rank
#316,202
of 7,710,434 ranked researchers
Rank in United States
#114,294
of 1,627,098
Works
49
Citations
9.8k
Citations per work
200.8
h-index
24
i10-index 27Top 24% in Molecular Biology
Shengfang Jin

What does Shengfang Jin research?

Shengfang Jin's work is mostly in Biochemistry, Genetics and Molecular Biology (53%), Medicine (22%).

Life Sciences: 26 works · 52.6% of their workBiochemistry, Genetics and Molecular Biology: 26 works · 52.6% of their workMolecular Biology: 16 works · 33.6% of their workCancer Research: 7 works · 13.8% of their workBiochemistry: 3 works · 5.2% of their workEverything else: 13 works · 25.9% of their workHealth Sciences: 11 works · 21.5% of their workMedicine: 11 works · 21.5% of their workOncology: 5 works · 9.5% of their workGenetics: 3 works · 6.0% of their workHematology: 3 works · 6.0% of their workTHEIR WORKShengfang Jin49works
Life Sciences53%Health Sciences22%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2652.6%
  2. Everything else1325.9%
    1. Medicine1121.5%
  1. 1Molecular Biology34% of their works
  2. 2Cancer Research14% of their works
  3. 3Oncology10% of their works
  4. 4Hematology6% of their works
  5. 5Genetics6% of their works
  6. 6Biochemistry5% of their works

Research topics

Which keywords describe Shengfang Jin's research?

The keywords of their largest research topics: HIF-1, Warburg Effect, Cancer, Metabolic Disorders, Glioblastoma, Temozolomide, Amino Acid Transporters and D-Serine.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. HIF-1141 topic
  2. Warburg Effect141 topic
  3. Cancer82 topics
  4. Metabolic Disorders82 topics
  5. Glioblastoma71 topic
  6. Temozolomide71 topic
  7. Amino Acid Transporters51 topic
  8. D-Serine51 topic
  9. AML41 topic
  10. Acute Myeloid Leukemia41 topic
  11. Genome Engineering41 topic
  12. RNA-Guided41 topic
  13. Biochemical Genetics31 topic
  14. DNA Damage31 topic
  15. DNA Methylation31 topic
  16. Histone Modification31 topic
  17. Newborn Screening31 topic
  18. Repair31 topic

Where does Shengfang Jin work?

Shengfang Jin's main affiliation in the publication record is Agios Pharmaceuticals (United States), United States.

How many publications and citations does Shengfang Jin have?

OpenAlex counts 49 works and 9,841 citations for Shengfang Jin, an h-index of 24, ranking #316,202 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Shengfang Jin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.